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Abstract
Background: Due to high rates of multiple birth and preterm birth following fertility treatment, the rates of
mortality and morbidity among births following fertility treatment were higher than those conceived
spontaneously. However, it is unclear whether the rates of adverse neonatal outcomes remain higher for very
preterm (<32 weeks gestational age) singletons born after fertility treatment. This study aims to compare adverse
neonatal outcomes among very preterm singletons born after fertility treatment including assisted reproductive
technology (ART) hyper-ovulution (HO) and artificial insemination (AI) to those following spontaneous conception.
Methods: The population cohort study included 24069 liveborn very preterm singletons who were admitted to
Neonatal Intensive Care Unit (NICU) in Australia and New Zealand from 2000 to 2010. The in-hospital neonatal
mortality and morbidity among 21753 liveborn very preterm singletons were compared by maternal mode of
conceptions: spontaneous conception, HO, ART and AI. Univariate and multivariate binary logistic regression analysis
was used to examine the association between mode of conception and various outcome factors. Odds ratio (OR)
and adjusted odds ratio (AOR) and 95% confidence interval (CI) were calculated.
Results: The rate of small for gestational age was significantly higher in HO group (AOR 1.52, 95% CI 1.02–2.67) and
AI group (AOR 2.98, 95% CI 1.53–5.81) than spontaneous group. The rate of birth defect was significantly higher in
ART group (AOR 1.71, 95% CI 1.36–2.16) and AI group (AOR 3.01, 95% CI 1.47–6.19) compared to spontaneous
group. Singletons following ART had 43% increased odds of necrotizing enterocolitis (AOR 1.43, 95% CI 1.04–1.97)
and 71% increased odds of major surgery (AOR 1.71, 95% CI 1.37–2.13) compared to singletons conceived
spontaneously. Other birth and NICU outcomes were not different among the comparison groups.
Conclusions: Compared to the spontaneous conception group, risk of congenital abnormality significantly
increases after ART and AI; the risk of morbidities increases after ART, HO and AI. Preconception planning should
include comprehensive information about the benefits and risks of fertility treatment on the neonatal outcomes.
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Background
The latest report of Australia’s mothers and babies
shows that 25113 of the 301810 babies (8.3%) born in
Australia in 2012 were preterm (<37 weeks gestational
age), the most common cause of death among infants
[1]. Worldwide, around 14.9 million babies were born
preterm in 2010 (11.1% of total birth in the same year).
Of these, about 5% were extreme preterm (<28 weeks),
11% were very preterm (28–31 weeks gestational age)
and 84% moderate to late preterm (32–36 weeks gesta-
tional age) [2]. In comparison, of preterm births in
Australia in 2012, 11% were extreme preterm, 9% were
very preterm and 80% were moderate to late preterm
[1]. Evidence shows that extreme preterm and very pre-
term births are at increased risk of severe morbidity and
mortality compared to moderate preterm births (32–36
weeks) and term births (>36 weeks) [3].
With the advanced care in neonatal intensive care
units (NICU), the survival of very preterm babies has
been improved in recent years, especially in developed
countries. The 2012 annual report by the Australian and
New Zealand Neonatal Network (ANZNN) shows that
the survival rate before NICU discharge was 70% for
births of 24 weeks gestational age and 98% for births of
31 weeks gestational age [4]. The ANZNN data also
shows that the NICU survival rates varied by plurality,
with significantly higher survival rates for singletons
than for multiples.
The literature suggests that multiple birth is the most
significant risk factor of preterm birth and subsequent
adverse neonatal outcome [5]. Preterm birth occurred in
60.8% of twins and in 94.8% of higher order multiple
births compared to 6.9% of singletons [1]. The neonatal
death rates of twins (10.9 per 1,000 live births) and
higher order multiples (28.7 per 1,000 live births) were
significantly higher than that of singletons (2.1 per 1,000
live births) [1]. Given the higher rate of multiple preg-
nancy following assisted reproductive technology (ART),
births following ART were at increased risk of preterm
birth and subsequent adverse neonatal outcomes. Previ-
ous studies also reported increased morbidity and mor-
tality among births following ART compared to those
following spontaneous conception [6, 7]. However, it is
unclear whether increased risk of subsequent adverse
neonatal outcomes among very preterm singletons is re-
lated to ART treatment itself or more attributable to the
underlying subfertility [8]. The study using a population
cohort approach aims to compare adverse neonatal out-
comes among very preterm singletons born after fertility
treatment including ART, hyper-ovulation (HO) and
artificial insemination (AI) to those born following spon-
taneous conceptions. We hypothesized that very preterm
singletons following fertility treatment have increased
risk of morbidity and mortality.
Methods
Data
This study used data and definitions from the ANZNN
data collection. The ANZNN is collected annually from
all NICUs in Australia and New Zealand. Liveborn ba-
bies included in ANZNN are either born at less than
32 weeks gestation, or weighed less than 1,500 g at birth,
or those who received assisted ventilation or major sur-
gery (surgery that involved opening a body cavity). A re-
search dataset including all liveborn singletons (N =
24,069) of <32 weeks gestation born between 2000 and
2010 was supplied from ANZNN for this study. Of
these, 17696 (73.5%) were with birthweight < 1500 g,
9854 (40.9%) required assisted ventilation and 1946
(8.1%) had major surgery.
Main outcome measures
The primary outcomes are morbidity and mortality be-
fore NICU discharge. Outcome measures were cate-
gorised into conditions at birth and NICU
complications. Conditions at birth include small for ges-
tational age (SGA, <10th percentile for the gestation),
5 min APGAR score (less than 7 was categorised as
moderate/severe depressed), extreme low birth weight
(extreme LBW; <1000 g), intubation during resuscitation
and presence of congenital abnormalities (defined as
structural abnormalities including deformations that are
present at birth and diagnosed prior to separation from
care). SGA for non-ART singletons were estimated from
already published birthweight for gestational age per-
centile charts [9, 10]. SGA for ART singletons was esti-
mated using published birthweight percentiles by
gestational age for ART births [11]. NICU complications
include hyaline membrane disease, necrotizing entero-
colitis (NEC), intraventricular haemorrhage, retinopathy
of prematurity, major surgery and death.
Comparison group
Conditions at birth and NICU complications were com-
pared among liveborn singletons by four modes of con-
ceptions flagged the ANZNN database: spontaneous
conception (no fertility treatment used for this preg-
nancy), HO (any hormone therapy used to stimulate
ovulation), ART (any method of in-vitro handling oocyte
or embryos including in-vitro fertilisation, gamete intra-
fallopian transfer, zygote intra fallopian transfer) and AI.
ANZNN data collection does not have detailed informa-
tion about the ART fertilisation procedures, fresh or fro-
zen embryos, and the number of embryo transferred and
stage of embryo development (blastocyst or cleavage
stage). Other study factors include maternal age, ethni-
city, gestational age and maternal complications, includ-
ing pregnancy inducted hypertension in pregnancy (A
systolic blood pressure > 140 mmHg and/or diastolic
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blood pressure > 90 mmHg, or a rise in systolic blood
pressure > 25 mmHg and/or a rise in diastolic blood
pressure > 15 mmHg from a reading before conception
or in 1st trimester; confirmed by 2 readings 6 h apart),
antepartum haemorrhage (Significant haemorrhage in
the time from 20 weeks gestation to the end of second
stage of labour) and premature rupture of membranes
(Confirmed spontaneous rupture of membranes occur-
ring prior to the onset of labour and before 37 weeks
gestation).
Statistical analysis
Demographics characteristics (maternal age, aboriginal
status, gestational age, previous preterm birth and previ-
ous perinatal death) and other maternal conditions (pre-
mature rupture of membranes, pregnancy inducted
hypertension, antepartum haemorrhage and antenatal
steroid) were compared among mode of conception and
differences in the means and proportions were tested.
Analysis of variance was used for continuous variables
and Chi-square test was used for categorical variables.
Univariate and multivariate binary logistic regression
analysis was used to examine the association between
mode of conception and various outcome factors. Odds
ratio (OR) and adjusted odds ratio (AOR) (adjusted for
maternal age, gestational age, ethnicity, previous pre
term, previous prenatal death, maternal hypertension,
antepartum haemorrhage, PROM and antenatal steroid)
and 95% CI were calculated. The level of significance
was set at 0.05, and 95% CIs were used to minimize the
risk of chance findings. Statistical Package for Social Sci-
ences (SPSS, Inc., Chicago, IL, USA Version 21) was
used for data analysis.
Results
The information on mode of conception was available for
21,753 (90.4%) singletons. Among these, 94.4% (20,530/
21,753) of singletons were born following spontaneous
conception, 4.4% (953/21,753) after ART, 1% (216/21,753)
after HO, 0.2% (54/21,753) after AI. Figure 1 presents the
distribution of gestational age by the mode of conceptions.
The proportion of extreme preterm was 26.1% in AI
group, compared to 30.6% in ART group, 33.7% in HO
group and 32.9% in spontaneous conception group.
The average age of mother following ART (34.6 ±
4.7 years), AI (33.3 ± 4.7 years) and HO (30.2 ± 4.9 years)
was significantly higher compared to those who con-
ceived spontaneously (28.9 ± 6.3 years) (p < 0.01). Simi-
larly, the mean gestational age was significantly different
among four groups (p = 0.01) (Table 1). Compared to the
spontaneously conceived singletons, mothers of ART
singletons had higher proportions of pregnancy inducted
hypertension and use of antenatal steroids (p < 0.01).
Figure 2 shows the number of singletons admitted to
NICU by the mode of conceptions over the period of
10 years. NICU admissions for the singletons conceived
spontaneously and after ART treatment increased by
11.7% and 48.8% respectively from 2001–10.
The rates of adverse birth outcomes were higher in
HO, ART and AI singletons, compared to the spon-
taneous conception. In the univariate analysis, HO
was associated with SGA, and extreme LBW; ART
was associated with extreme LBW, intubation during
resuscitation and major malformation; and AI was as-
sociated with SGA and congenital abnormalities
(Table 2). Compared to very preterm singletons con-
ceived spontaneously, the odds of SGA was about 3
times higher for those after AI (AOR 2.98, 95% CI
Fig. 1 Distribution of gestational age of very preterm and extreme preterm singletons by mode of conceptions
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1.53–5.81) and 1.5 times higher for those after HO (AOR
1.52, 95% CI 1.02–2.67). Similarly, the odds of major ab-
normalities was 3 times (AOR 3.01, 95% CI 1.47–6.19)
higher for AI singletons and 1.7 times (AOR 1.71, 95% CI
1.36–2.16) higher for ART singletons than spontaneous
singletons. Other birth outcomes were not significantly
different between spontaneous conception group and the
three fertility treatment groups.
Table 1 Demographics of very preterm singletons by mode of conceptions
Spontaneous HO ART AI P valuea
(20,530) (216) (953) (54)
# % # % # % # %
Maternal age (years) Mean ± SD 28.87 ±6.3 30.36 ±4.9 34.64 ±4.7 33.33 ±4.7 <0.05b
Gestational age (weeks) Mean ± SD 28.44 ±2.5 28.12 2.4± 28.25 2.3± 28.19 2.3± 0.01
Aboriginal status
Yes 1274 6.2 4 1.9 10 1.0 0 0.0 <0.05
no 17079 83.2 186 86.1 830 87.1 52 96.3
Not stated 2177 10.6 26 12 113 11.9 2 3.7
Previous preterm birth
Yes 3928 19.1 24 11.1 78 8.2 7 13.0 <0.05
No 16506 80.4 192 88.9 874 91.7 47 87.0
Not stated 96 0.5 0 0.0 1 0.1 0 0.0
Previous perinatal death
Yes 1239 6.0 11 5.1 38 4.0 5 9.3 <0.05
No 19218 93.6 205 94.9 915 96.0 49 90.7
Not stated 73 0.4 0 0.0 0 0.0 0 0.0
Premature rupture of membranes
Yes 5243 25.5 44 20.4 246 25.8 10 18.5 0.301
No 15256 74.3 171 79.2 704 73.9 44 81.5
Not stated 31 0.2 1 0.5 3 0.3 0 0.0
Pregnancy inducted hypertension
Yes 3619 17.6 58 26.9 199 20.9 20 37.0 <0.05
No 16895 82.3 157 72.7 752 78.9 34 63.0
Not stated 16 0.1 1 0.5 2 0.2 0 0.0
Antepartum haemorrhage
Yes 5028 24.5 47 21.8 262 27.5 13 24.1 0.063
No 15488 75.4 168 77.8 689 72.3 41 75.9
Not stated 14 0.1 1 0.5 2 0.2 0 0.0
Antenatal steroid
None 2724 13.3 17 7.9 76 8 3.0 5.6 <0.05
Incomplete 5514 26.9 56 25.9 234 24.6 13 24.1
Complete 9377 45.7 111 51.4 468 49.1 33 61.1
More than 7 days 2548 12.4 31 14.4 156 16.4 5 9.3
Not stated 367 1.8 1 0.5 19 2.0 0 0.0
Gender of baby
Male 11279 54.9 122 56.5 517 54.2 33 61.1 0.98
Female 9233 45.0 94 43.5 436 45.8 21 38.9
Ambiguous 2 0.0 0 0.0 0 0.0 0 0.0
Not stated 16 0.1 0 0.0 0 0.0 0 0.0
a chi square test.
b Analysis of variance
Wang et al. BMC Pregnancy and Childbirth  (2017) 17:50 Page 4 of 10
Fig. 2 Number of very preterm and extreme preterm singletons by mode of conceptions 2001–2010
Table 2 Birth conditions of very preterm singletons by mode of conceptions
Number Percent OR (95% CI) AOR (95% CI)a
Small for gestational age
Spontaneous conception 1833 8.9 Ref Ref
HO 35 16.2 1.97 (1.37–2.84) 1.52 (1.02–2.67)
ART 102 10.7 1.22 (0.99–1.51) 1.09 (0.87–1.38)
AI 16 29.6 4.29 (2.39–7.71) 2.98 (1.53–5.81)
5 min APGAR (Mod/ severe depressed)
Spontaneous conception 3659 18.0 Ref Ref
HO 35 16.2 0.88 (0.61–1.27) 0.78 (0.52–1.18)
ART 176 18.6 1.04 (0.88–1.23) 1.02 (0.85–1.24)
AI 10 18.5 1.04 (0.52–2.06) 1.07 (0.52–2.22)
Extreme Low birth weight (<1000 g)
Spontaneous conception 6676 32.5 Ref Ref
HO 88 40.7 1.43 (1.09–1.87) 1.13 (0.72–1.79)
ART 351 36.8 1.21 (1.06–1.38) 1.11 (0.88–1.40)
AI 22 40.7 1.43 (0.83–2.46) 1.01 (0.43–2.42)
Intubation during resuscitation
Spontaneous conception 8405 41.0 Ref Ref
HO 101 46.8 1.26 (0.97–1.65) 1.16 (0.84–1.60)
ART 440 46.3 1.24 (1.09–1.41) 1.11 (0.94–1.30)
AI 22 40.7 0.97 (0.57–1.70) 0.87 (0.46–1.64)
Congenital abnormalities
Spontaneous conception 1197 6.0 Ref Ref
HO 10 4.9 0.80 (0.42–1.51) 0.80 (0.42–1.52)
ART 93 10.1 1.75 (1.40–2.19) 1.71 (1.36–2.16)
AI 9 16.7 3.12 (1.52–6.40) 3.01 (1.47–6.19)
a Adjusted for maternal age, gestational age, ethnicity, previous pre term, previous prenatal death, maternal hypertension, antepartum haemorrhage, premature
rupture of membranes and antenatal steroid
Significant results are in bold
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The multivariate analysis shows that very preterm sin-
gletons born after ART have 43% higher odds of having
NEC (AOR 1.43, 95% CI 1.04–1.97) and 71% higher
odds of having major surgery (AOR 1.71, 95% CI 1.37–
2.13) compared to those conceived spontaneously. Data
stratification shows that major surgery was closely re-
lated to congenital abnormalities. Major surgery was
reported in 33% and 11% of ART singletons with and
without congenital abnormalities respectively (p value
<0.05). Other NICU outcomes were not significantly dif-
ferent spontaneous conception group and the three
fertility treatment groups (Table 3).
Discussion
This bi-national population study showed that the rates
of some adverse neonatal outcomes are significantly in-
creased among the very preterm singletons following fer-
tility treatment. Compared to the spontaneous
conception group, ART and AI groups had 1.7 times and
3.0 times increased odds of major malformation. Very
preterm singletons following HO and AI had 1.5 times
and 3.0 times increased odds of SGA than spontaneous
conception group. ART is associated with 43% and 71%
higher odds of NEC and major surgery compared to
spontaneous conception group.
Table 3 NICU outcomes of very preterm singletons by mode of conceptions
Number Percent OR (95% CI) AOR (95% CI)a
Hyaline membrane disease
Spontaneous conception 14574 71.9 Ref Ref
HO 154 72.0 1.00 (0.74–1.36) 0.87 (0.62–1.21)
ART 724 76.9 1.30 (1.11–1.52) 1.18 (0.99–1.40)
AI 38 72.1 0.93 (0.52–1.67) 0.75 (0.41–1.42)
Necrotizing enterocolitis
Spontaneous conception 817 4.0 Ref Ref
HO 3 1.4 0.34 (0.11–1.04) 0.33 (0.10–1.05)
ART 49 5.2 1.30 (0.97–1.75) 1.43 (1.04–1.97)
AI 2 3.7 0.92 (0.22–3.80) 0.85 (0.20–3.60)
Intra ventricular haemorrhage
Spontaneous conception 4327 23.1 Ref Ref
HO 53 26.0 1.17 (0.85–1.60) 1.23 (0.86–1.75)
ART 229 25.6 1.14 (0.98–1.33) 1.20 (1.00–1.43)
AI 12 23.1 0.99 (0.52–1.90) 1.21 (0.61–2.40)
Retinopathy of prematurity
Spontaneous conception 3896 26.6 Ref Ref
HO 49 31.6 1.27 (0.91–1.79) 1.04 (0.70–1.52)
ART 187 27.2 1.03 (0.87–1.22) 1.00 (0.82–1.24)
AI and other 10 23.3 0.83 (0.41–1.70) 0.99 (0.44–2.17)
Major surgery
Spontaneous conception 1642 8.1 Ref Ref
HO 23 10.7 1.37 (0.89–2.11) 1.27 (0.79–2.02)
ART 122 12.9 1.70 (1.39–2.06) 1.71 (1.37–2.13)
AI 6 11.1 1.43 (0.61–2.34) 1.00 (0.389–2.60)
Deaths
Spontaneous conception 1852 9.0 Ref Ref
HO 20 9.3 1.02 (0.65–1.63) 0.67 (0.38–1.18)
ART 98 10.3 1.15 (0.93–1.43) 1.11 (0.86–1.42)
AI 9 16.7 2.01 (0.98–4.13) 2.10 (0.93–4.76)
a Adjusted for maternal age, gestational age, ethnicity, previous pre term, previous prenatal death, maternal hypertension, antepartum haemorrhage, premature
rupture of membranes and antenatal steroid
Significant results are in bold
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The literature shows that fertility treatments including
ART, AI, HO and use of Clomiphene are associated with
increased risk of adverse pregnancy and perinatal out-
comes [12]. Very preterm and preterm birth are such ad-
verse perinatal outcomes associated fertility treatment,
and are leading causes of other morbidity and mortality
[13, 14]. We selected very preterm singletons as our
study population which reduced the confounding and
interaction effects between the fertility treatment and
adverse perinatal outcomes due to multiple pregnancies
and prematurity. Agreed with the literature, our findings
suggested that very preterm singletons following ART
and other fertility treatment are at increased risk of fetal
and neonatal outcomes [15–18].
A number of studies reported higher incidence of low
birthweight among births following fertility treatment
than spontaneous births [6, 19–22]. Since our study popu-
lation was limited to very preterm singletons, the low
birthweight is not a measure relevant to our study popula-
tion. Instead, we used SGA to measure birthweight out-
comes. Babies are SGA if their weights are below the 10th
percentile for their gestational ages. Although the majority
babies born SGA catch up in growth at 2 years old, SGA
babies are at increased risk of morbidity and mortality [7].
Apart from genetic reasons, SGA is related to fetal, mater-
nal and placental conditions. Subfertility, one of the ma-
ternal conditions is associated with increased risk of SGA
[23]. Since all couples who access ART treatment have
some level of subfertility, they are more likely to have a
SGA baby [17]. Zhu and colleagues also reported a high
rate of SGA in sub-fertile women regardless of ART treat-
ment [23]. Even for very preterm singletons, those born to
mothers following fertility treatment, an indicator of sub-
fertility, have a higher rate of SGA than those following
spontaneous conceptions.
Congenital anomaly is the one of the leading causes of
neonatal death among the preterm babies [24]. Many
studies have reported an increased rate of congenital
anomalies among births following fertility treatment
compared to spontaneous births [18, 25, 26], with the
prevalence of congenital anomalies ranges from 4–9%
among ART births according to various studies [12, 17,
27], and 4–6% in general population [28, 29]. Even
though our rates are comparable with other published
studies, it should be interpreted with cautions as we only
included very preterm births in this study. Increase risk
of congenital abnormality may be due to generally in-
creased risk of congenital amorality in ART group or
due to shift of gestational duration toward lower values
among a normal rate of congenital amorality. Moreover,
congenital anomalies may be on the casual pathway to
low birth weight or preterm birth [30, 31].
Presence of congenital abnormalities is one of the
major causes of surgery and other adverse neonatal
outcomes in the neonatal period [32]. The most com-
mon reasons for major surgery in our study include vas-
cular system (418 cases), skeletal system (151 cases),
gastrointestinal (146 cases), genital tract (136 cases) and
respiratory (105 cases). The higher rate of major surgery
among ART singletons in our study is likely due to asso-
ciated congenital abnormalities. Rates of major surgery
were significantly in ART singletons with congenital ab-
normalities, compared to ART singletons without con-
genital abnormalities (p value <0.05). Similarly we need
to assume that a chain of event might happen and in
most cases birth conditions are related to the common
NICU outcomes including NEC, intraventricular haem-
orrhage, hyaline membrane disease and retinopathy of
prematurity among the very preterm babies [24]. Al-
though the rates of all conditions were high in the ART
group, only NEC was significantly associated with the
ART in this study.
Necrotizing Enterocolitis is one of the most common
severe diseases among preterm births, with high morbid-
ity and mortality. Yee and colleagues suggested that the
mortality for NEC can be up to 50% and 20–40% cases
may need surgical treatment [33]. The rates of NEC in
our study were 5.2% among ART and 4.0% among spon-
taneous conceived very preterm singletons. These are
within the range between 3% and 15% reported by other
studies [34]. The increase rate of NEC and very preterm
ART singletons in our study remains unclean as the cause
necrotizing enterocolitis is incompletely understood. Neu
and Walker suggested that the cause of NEC is multifac-
torial, but it is preventable by withholding enteral feed-
ings, using enteral antibiotics, feeding with expressed
breast milk, and administering probiotic agents [35].
Death rates in ART treatment groups were high in
our study, compared to the spontaneous conception
group, however the difference was not statistically sig-
nificant. In a previous NICU study in Australia, low
mortality was observed in the ART twins and triplets
compare to spontaneously conceived twins and trip-
lets and authors attributed it “protective effect” to the
“dichorionic pregnancies” and specialized care offered
to the ART mothers [20]. Another study reported low
rate of death among the babies born after the ART
treatment and authors attributed it to the single em-
bryo transfer practices and comparison of ART
healthy babies with sick non ART babies [24]. How-
ever both these studies included multiple pregnancies
in the analysis and there is ample of evidence sug-
gests that ART singletons have high mortality com-
pared to non-ART singletons [21].
Survival rates of the very preterm babies have been
improved in the last few decades due to increase use
of ventilator support, steroids and surfactants [36 ,37].
However the outcome is still poor among the babies
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born after the fertility treatment. It is not clear
whether this is due to complication of treatment such
as congenital abnormalities or due to maternal condi-
tions such as pregnancy induced hypertension. These
babies are at risk of long term neurological and behav-
ioural complications which are not well studied [38]. The
outcome in the very preterm singletons also may be differ-
ent as it is associated with the gestational age. Among the
preterm babies, the mortality is generally very high among
the those born at 23 weeks (84%) compared to those born
at 28 week (13%) [39]. The potential risk of very preterm
birth and subsequent neonatal morbidity and mortality
should be explained to the women undergoing ART
treatment.
There are some limitations of this study, which are im-
portant while interpreting the results. In the ANZNN
database four categories are mentioned under the flag
“Assisted conception”: spontaneous conception, HO,
ART and AI. It is possible that some HO and AI single-
tons were misreported into spontaneous conception
group given the small number of HO and AI singletons
were identified in this study. However, we are unable to
track the assisted conception from other records. Simi-
larly we are unable to track the pregnancies characterises
including gestational sacs and fetal hearts. It is suggested
that singletons born as a result of vanish twins/triples
have increased risk of adverse perinatal outcomes those
born with initial one gestational sac/fetal heart (Wang et
al. 2009). This is especially relavent to HO and ART sin-
gletons where multiple gestational sacs pregnancies are
prevalent [12, 14].
ART included complex procedures such as oocyte col-
lection, ICSI procedure, cleavage stage transfer, frozen
embryo transfer, and number of embryos transferred.
Detailed information on types of cycle, ART procedures,
and embryo transfers which may be associated with ad-
verse maternal and fetal outcomes is not available in the
database [40, 41]. For example high rate of congenital
abnormalities are reported after the ICSI procedure [12]
and cleavage stage transfer [42]. Perinatal outcomes are
usually favourable following frozen embryo transfers
than fresh embryo transfers [13, 43]. Similarly, double
embryo transfer is related to multiple birth [44] and
multiple births had higher chances of congenital abnor-
malities than the singletons [45]. Compared to the single
embryo transfers, 1.5 fold increase in fetal death has
been reported for births following double embryo trans-
fers [14].
Another limitation of this study was restricting ana-
lysis to only extreme preterm and very (<32 weeks)
births, which limits the study generalisation to all
preterm births. ANZNN data collection includes
births of gestational age < 32 weeks in Australia and
New Zealand, however the evidence suggests that the
rate of preterm in the developed countries are mainly
increased for the moderate preterm birth (32–36
weeks gestation) [46]. As ANZNN only includes ba-
bies of birth weight <1,500 g, many LBW babies may
not be admitted to NICU and were not included from
the study. Comparison between babies of birth weight
<1,500 g and those of birth weight 1500–2499 g is im-
portant since the later have less complications com-
pared to very preterm babies. Another limitation of
this study is that we are unable to identify women
who have a history of subfertility but conceived spon-
taneously. These women were included in the spon-
taneous conception group although they were
inherently different from women without history of
infertility [47, 48]. Previous studies also show that
maternal and childhood complications are more com-
mon in subfertile women compared to fertile women
[49–51]. This indicates that some biological factors
may play a role however there is limited evidence.
Our multivariate analysis was adjusted for maternal
age, gestational age, ethnicity, previous pre term, pre-
vious prenatal death, maternal hypertension, antepar-
tum haemorrhage, PROM and antenatal steroid. The
residual confounding may exist as we were unable to
adjust factors such as maternal smoking, BMI, loca-
tion and size of NICU, method of delivery and paren-
tal social-economic status. Moreover, increase risk of
congenital abnormality and other morbidities after
fertility treatments in NICU setting may not be gen-
eralised to the all babies born after fertility treatment.
We only examined morbidity and mortality among
cases admitted to NICUs. Fetal deaths and termina-
tions due to prenatally diagnosed congenital abnor-
mality are not included. Finally the comparison was
made between spontaneous conceived singletons and
those following ART, HO and AI. We did not make
comparison across fertility treatment groups due to
small sample size in HO and AI groups. Further stud-
ies need be conducted by directly comparing out-
comes in sub-fertile/infertile women conceived with
or without fertility treatment and type of fertility
treatment [52, 53].
Conclusions
Very preterm (<32 weeks gestational age) singletons
following HO, ART and AI had higher rates of some
neonatal morbidity than spontaneous singletons. Com-
pared to the spontaneous conception group, risk of birth
defects significantly increases after ART and AI; the risk
of morbidities increases after ART, HO and AI. Precon-
ception planning should include comprehensive infor-
mation about the benefits and risks of fertility treatment
on the neonatal outcomes.
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